ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,064Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 559

$430K Total Retail Price of All Prescriptions

Rank: 55 out of 559

455 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 455 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 455 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,236 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 570 461 1 2
LISINOPRIL 341 269 2 1
SIMVASTATIN 281 243 3 3
METFORMIN HCL 254 213 4 5
HYDROCODONE-ACETAMINOPHEN 233 166 S3 5 7
HYDROCHLOROTHIAZIDE 211 180 6 8
LOVASTATIN 211 168 6 10
AMLODIPINE BESYLATE 210 174 8 6
OMEPRAZOLE 189 120 9 4
METOPROLOL SUCCINATE 181 143 10 16
LOSARTAN POTASSIUM 162 155 11 14
ATENOLOL 138 135 12 15
GABAPENTIN 138 88 12 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 137 105 14 18
TRAZODONE HCL 124 68 15 28
FUROSEMIDE 124 101 15 11
RANITIDINE HCL 118 95 17 26
FLUTICASONE PROPIONATE 117 112 18 22
ATORVASTATIN CALCIUM 114 98 19 20
ALENDRONATE SODIUM 107 100 20 13
PROAIR HFA 105 67 21 29
DOXAZOSIN MESYLATE 103 68 22 43
CITALOPRAM HBR 97 79 23 21
ZOLPIDEM TARTRATE 96 68 24 17
METOPROLOL TARTRATE 95 95 25 12
CRESTOR 92 73 26 33
LOSARTAN-HYDROCHLOROTHIAZIDE 87 85 27 52
WARFARIN SODIUM 78 74 28 24
TAMSULOSIN HCL 72 68 29 25
GLIPIZIDE ER 69 41 30 77
FLUOXETINE HCL 66 46 31 37
JANUVIA 62 43 32 50
ALLOPURINOL 61 39 33 34
DONEPEZIL HCL 61 61 33 36
LANTUS 59 47 35 40
METFORMIN HCL ER 57 27 36 75
TRAMADOL HCL 55 40 37 27
SERTRALINE HCL 52 34 38 19
PAROXETINE HCL 50 41 39 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.